Who is sponsoring NCT04185064?

NCT04185064 is sponsored by Encore Research Inc..

What drugs are being tested in NCT04185064?

Interventions in NCT04185064: Game Ready ATX shoulder wrap; Game Ready GRPro 2.1, Standard Care.

What condition does NCT04185064 study?

NCT04185064 studies Shoulder Injuries, Shoulder Disease.

Is NCT04185064 still recruiting?

NCT04185064 is currently completed. Last updated 2 February 2024.

Last reviewed 2024-02-02 · How we verify

NCT04185064

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cryopneumatic Device After Shoulder Surgeries

Completed NA Last updated 2 February 2024

What this trial tests

NA trial testing Game Ready ATX shoulder wrap; Game Ready GRPro 2.1 in Shoulder Injuries in 200 participants. Completed in 17 May 2023.

Timeline

1 September 2020

Primary endpoint
17 May 2023

17 May 2023

Quick facts

Lead sponsor	Encore Research Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	200
Start date	1 September 2020
Primary completion	17 May 2023
Estimated completion	17 May 2023
Sites	5 locations across Canada

Drugs / interventions tested

Game Ready ATX shoulder wrap; Game Ready GRPro 2.1
Standard Care — full drug profile →

Conditions studied

Shoulder Injuries — all drugs for Shoulder Injuries →
Shoulder Disease — all drugs for Shoulder Disease →

Sponsor

Encore Research Inc.

Who can join

18 and older, any sex, with Shoulder Injuries or Shoulder Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study randomize patients to receive either a cryopneumatic device or standard care (ice and ice packs) following open or arthroscopic shoulder surgeries. The primary objective is to determine the impact of the cryopneumatic device on post-surgery pain management, while secondary objectives are to detemine the effect on pain, patient eperience, quality of life, narcotic consumption and time to stop narcotic usage. Patients who do not wish to participate in the randomized portion of the trial will be invited to participate in an observational cohort who will all receive the cryopneumatic device. Patients who wish to enter this cohort will not have the device provided to them for free, and will either use their insurance or pay for the device, in order to determine if patients who pay demonstrate different outcomes from the patients receiving the device for free in the RCT.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Cryo-Pneumatic Compression Results in a Significant Decrease in Opioid Consumption After Shoulder Surgery: A Multicenter Randomized Controlled Trial.
Khan M, Phillips SA, Mathew P, Venkateswaran V, et al · · 2024 · cited 3× · PMID 39165152 · DOI 10.1177/03635465241270138

Verify or expand the search:

Other recruiting trials for Shoulder Injuries

Currently open trials in the same condition.

NCT07257081 — Effect of Combining a Posterosuperior Humeral Notch Filling With a Coracoid Bone Block on the Rate of Return to Sport · NA · active not recruiting
NCT06866054 — Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery · NA · recruiting
NCT07055685 — Effects of Upper Limb PRT With CSE on Pain, Core Strength and ULB in Cricket Fast Bowlers With Shoulder Injury · NA · active not recruiting
NCT06485934 — Kinesiophobia Scale for the Upper Extremity · recruiting
NCT06016257 — Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04185064 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Encore Research Inc.
Last refreshed: 2 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04185064.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing